I agree that this site is using cookies. You can find further informations here.
X
Neuwirth, Rachel
44  results:
Search for persons X
?
1

Safety and pharmacodynamics of a single infusion of danavor..:

Mignot, Emmanuel ; Bogan, Richard K ; Emsellem, Helene...
SLEEP.  46 (2023)  9 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
2

A randomized phase 2 study of sapanisertib in combination w..:

Han, Sileny N. ; Oza, Amit ; Colombo, Nicoletta...
Gynecologic Oncology.  178 (2023)  - p. 110-118 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Safety and pharmacodynamics of a single infusion of danavor..:

Bogan, Richard K. ; Maynard, James P. ; Neuwirth, Rachel...
Sleep Medicine.  107 (2023)  - p. 229-235 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Sapanisertib plus Fulvestrant in Postmenopausal Women with ..:

García-Sáenz, José Á. ; Martínez-Jáñez, Noelia ; Cubedo, Ricardo...
Clinical Cancer Research.  28 (2022)  6 - p. 1107-1116 , 2022
Link: https://doi.org/10.1158/..
 
?
5

Safety and pharmacodynamics of a single infusion of TAK-925..:

Mignot, Emmanuel ; Bogan, Richard ; Emsellem, Helene...
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
6

Safety and efficacy of TAK-925 in adults with obstructive s..:

Rubens, Robert ; Olsson, Tina ; Neuwirth, Rachel...
Neurology.  96 (2021)  15_supplement - p. , 2021
Link: https://doi.org/10.1212/..
 
?
7

Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) ..:

Voss, Martin H. ; Gordon, Michael S. ; Mita, Monica...
British Journal of Cancer.  123 (2020)  11 - p. 1590-1598 , 2020
Link: https://doi.org/10.1038/..
 
?
8

Phase I study of the investigational oral mTORC1/2 inhibito..:

Moore, Kathleen N. ; Bauer, Todd M. ; Falchook, Gerald S....
ESMO Open.  3 (2018)  2 - p. e000291 , 2018
Link: https://doi.org/10.1136/..
 
?
9

Population Pharmacokinetic Analysis of Bortezomib in Pediat..:

Hanley, Michael J. ; Mould, Diane R. ; Taylor, Timothy J....
The Journal of Clinical Pharmacology.  57 (2017)  9 - p. 1183-1193 , 2017
Link: https://doi.org/10.1002/..
 
?
10

Impact of concomitant dexamethasone dosing schedule on bort..:

Kumar, Shaji K. ; Laubach, Jacob P. ; Giove, Thomas J....
British Journal of Haematology.  178 (2017)  5 - p. 756-763 , 2017
Link: https://doi.org/10.1111/..
 
?
11

TAK‐228 (formerly MLN0128), an investigational oral dual TO..:

Ghobrial, Irene M. ; Siegel, David S. ; Vij, Ravi...
American Journal of Hematology.  91 (2016)  4 - p. 400-405 , 2016
Link: https://doi.org/10.1002/..
 
?
12

A phase I dose-escalation study of TAK-733, an investigatio..:

Adjei, Alex A. ; LoRusso, Patricia ; Ribas, Antoni...
Investigational New Drugs.  35 (2016)  1 - p. 47-58 , 2016
Link: https://doi.org/10.1007/..
 
?
13

Sustained Exposure to the Investigational Kisspeptin Analog..:

MacLean, David B. ; Matsui, Hisanori ; Suri, Ajit..
The Journal of Clinical Endocrinology & Metabolism.  99 (2014)  8 - p. E1445-E1453 , 2014
Link: https://doi.org/10.1210/..
 
?
14

Phase II study of bortezomib in combination with rituximab,..:

Craig, Michael ; Hanna, Wahid T. ; Cabanillas, Fernando...
British Journal of Haematology.  166 (2014)  6 - p. 920-928 , 2014
Link: https://doi.org/10.1111/..
 
?
15

Dose-escalating and pharmacological study of bortezomib in ..:

Leal, Ticiana B. ; Remick, Scot C. ; Takimoto, Chris H....
Cancer Chemotherapy and Pharmacology.  68 (2011)  6 - p. 1439-1447 , 2011
Link: https://doi.org/10.1007/..
 
1-15